1-4 of 4
Claudia Schmoor, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Trial on GvHD Prophylaxis with or without Anti-Human T-Lymphocyte Immunoglobulin ATG-Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation from Matched Unrelated Donors: Final Long-Term Results after 8.6 Years Median Follow-up

Jürgen Finke, MD, Claudia Schmoor, PhD, Wolfgang A Bethge, MD, Hellmut Ottinger, Priv.-Doz. Dr. MD, Matthias Stelljes, Liisa Volin, MD PhD, Dominik Heim, MD, Hartmut Bertz, MD, Olga Grishina, MD, Gerard Socie
Journal: Blood
Blood (2015) 126 (23): 853.
https://doi.org/10.1182/blood.V126.23.853.853
Published: 2015
Journal Articles

Long-Term Follow-up of Therapy-Related MDS and AML Patients Treated with Allogeneic Hematopoietic Cell Transplantation Reveals Substantial 10 Year Survival and Comparably Low Treatment-Related Mortality

Björn Hackanson, MD, Claudia Schmoor, PhD, Hartmut Bertz, Reinhard Marks, Ralph Wäsch, MD, Robert Zeiser, Jürgen Finke, MD
Journal: Blood
Blood (2014) 124 (21): 1264.
https://doi.org/10.1182/blood.V124.21.1264.1264
Published: 2014
Journal Articles

Randomized Trial On GvHD Prophylaxis with or without Anti T Cell Globulin ATG Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors: Updated Results and Evaluation of the European Group for Blood and Marrow Transplantation (EBMT) Risk Score.

Juergen Finke, Claudia Schmoor, PhD, Wolfgang A. Bethge, MD, Hellmut Ottinger, MD, Matthias Stelljes, MD, Axel R. Zander, MD, Liisa Volin, Dominik Heim, MD, Rainer Schwerdtfeger, Hartmut Bertz, Olga Grishina, MD, Gerard Socie
Journal: Blood
Blood (2012) 120 (21): 3090.
https://doi.org/10.1182/blood.V120.21.3090.3090
Published: 2012
Journal Articles

Continued Low-Dose Decitabine (DAC) Is an Active First-Line Treatment in All Cytogenetic Subgroups of Older AML Patients: Results of the FR00331 Multicenter Phase II Study.

Michael Lübbert, MD, Björn Rüter, MD, Rainer Claus, MD, Mathias Schmid, MD, Ulrich Germing, MD, Hartmut Eimermacher, MD, Arnold Ganser, MD, Uwe Platzbecker, MD, Oliver Galm, MD, Wolfram Brugger, MD, Gerhard Heil, MD, Pierre W. Wijermans, MD, Dietmar Pfeifer, PhD, Claudia Schmoor, PhD, Hartmut Döhner, MD
Journal: Blood
Blood (2007) 110 (11): 300.
https://doi.org/10.1182/blood.V110.11.300.300
Published: 2007